Search research articles
Contact Us
Filters
Showing results (151-160 of 248) with videos related to
Page
of 25
Sort By:
ACS Nano
|
June 20, 2014
Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatment
Federico Fenaroli, David Westmoreland, Jørgen Benjaminsen, et al.
ALTEX
|
March 18, 2016
Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier
Anna Kuehn, Stephanie Kletting, Cristiane de Souza Carvalho-Wodarz, et al.
European Urology
|
June 10, 2022
Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial
Simon J Crabb, Gareth Griffiths, Denise Dunkley, et al.
Trials
|
May 31, 2020
Patient-reported outcome measures for monitoring primary care patients with depression (PROMDEP): study protocol for a randomised controlled trial
Tony Kendrick, Michael Moore, Geraldine Leydon, et al.
British Journal of Cancer
|
August 18, 2018
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
Simon Gollins, Nicholas West, David Sebag-Montefiore, et al.
Plant Physiology
|
November 22, 2005
Evaluation of the antimicrobial activities of plant oxylipins supports their involvement in defense against pathogens
Isabelle Prost, Sandrine Dhondt, Grit Rothe, et al.
Clinical Genitourinary Cancer
|
April 10, 2023
Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors Survey
Gagan Prakash, Amandeep Arora, Marco Bandini, et al.
European Urology
|
December 4, 2014
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma
Thomas Geldart, John Chester, Angela Casbard, et al.
Trials
|
September 10, 2017
Uva-ursi extract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial
Jeanne Trill, Catherine Simpson, Frances Webley, et al.
F1000Research
|
October 23, 2020
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial
Andrew Davies, Sharon Barrans, Cathy Burton, et al.
Page
of 25
Search research articles
Search
Showing results (151-160 of 248) with videos related to
Sort By:
Page
of 25
ACS Nano
|
June 20, 2014
Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatment
Federico Fenaroli, David Westmoreland, Jørgen Benjaminsen, et al.
ALTEX
|
March 18, 2016
Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier
Anna Kuehn, Stephanie Kletting, Cristiane de Souza Carvalho-Wodarz, et al.
European Urology
|
June 10, 2022
Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial
Simon J Crabb, Gareth Griffiths, Denise Dunkley, et al.
Trials
|
May 31, 2020
Patient-reported outcome measures for monitoring primary care patients with depression (PROMDEP): study protocol for a randomised controlled trial
Tony Kendrick, Michael Moore, Geraldine Leydon, et al.
British Journal of Cancer
|
August 18, 2018
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS
Simon Gollins, Nicholas West, David Sebag-Montefiore, et al.
Plant Physiology
|
November 22, 2005
Evaluation of the antimicrobial activities of plant oxylipins supports their involvement in defense against pathogens
Isabelle Prost, Sandrine Dhondt, Grit Rothe, et al.
Clinical Genitourinary Cancer
|
April 10, 2023
Variations in Penile Cancer Management: Results From the Global Society of Rare Genitourinary Tumors Survey
Gagan Prakash, Amandeep Arora, Marco Bandini, et al.
European Urology
|
December 4, 2014
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinoma
Thomas Geldart, John Chester, Angela Casbard, et al.
Trials
|
September 10, 2017
Uva-ursi extract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial
Jeanne Trill, Catherine Simpson, Frances Webley, et al.
F1000Research
|
October 23, 2020
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial
Andrew Davies, Sharon Barrans, Cathy Burton, et al.
Page
of 25